Hjem › Kronisk fase myeloid leukæmi › Californien
Kronisk fase myeloid leukæmi kliniske forsøg i Californien
5 studier for Kronisk fase myeloid leukæmi søger deltagere på steder i Californien.
Officiel studietekst (engelsk)
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1062, Duarte
- Ascentage Investigative Site #1099, Irvine
- Ascentage Investigative Site #1075, La Jolla
- og 4 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06423911A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- City of Hope Medical Center, Duarte
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 75 · Alle køn · Opdateret 28. jul. 2026 · NCT07020533A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- Stockton Hematology Oncology Medical Group Inc, Stockton
- Lundquist Inst BioMed at Harbor, Torrance
RekruttererObservationsstudie
Alder 18 til 100 · Alle køn · Opdateret 20. jul. 2026 · NCT07091019Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
- Chao Family Comprehensive Cancer Center University of California, Irvine, Orange
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 10. mar. 2026 · NCT06229860A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- UC Irvine Health, Orange
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 12. jan. 2026 · NCT06163430Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.